NISA INVESTMENT ADVISORS, LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 312 filers reported holding NOVOCURE LTD in Q4 2021. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
NISA INVESTMENT ADVISORS, LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q1 2023$742
+20.3%
12,334
+46.6%
0.01%
+20.0%
Q4 2022$617
-99.9%
8,416
-11.2%
0.01%
-16.7%
Q3 2022$718,000
+513.7%
9,480
+462.6%
0.01%
+500.0%
Q2 2022$117,000
-42.6%
1,685
-31.5%
0.00%0.0%
Q1 2022$204,000
+20.7%
2,4600.0%0.00%0.0%
Q4 2021$169,000
-60.9%
2,460
-33.8%
0.00%
-66.7%
Q3 2021$432,000
-75.1%
3,718
-52.5%
0.00%
-72.7%
Q2 2021$1,738,000
+78.6%
7,833
+6.4%
0.01%
+83.3%
Q1 2021$973,000
+15.8%
7,359
+51.6%
0.01%
+20.0%
Q4 2020$840,000
+214.6%
4,853
+102.6%
0.01%
+150.0%
Q3 2020$267,000
+88.0%
2,3950.0%0.00%
+100.0%
Q2 2020$142,000
-27.2%
2,395
-17.4%
0.00%
-50.0%
Q1 2020$195,000
-0.5%
2,900
+24.5%
0.00%0.0%
Q4 2019$196,000
+19.5%
2,330
+6.4%
0.00%
+100.0%
Q3 2019$164,000
+23.3%
2,190
+4.3%
0.00%0.0%
Q2 2019$133,000
+31.7%
2,1000.0%0.00%0.0%
Q1 2019$101,000
+36.5%
2,100
-4.5%
0.00%0.0%
Q4 2018$74,000
-16.9%
2,200
+29.4%
0.00%0.0%
Q3 2018$89,000
+67.9%
1,7000.0%0.00%0.0%
Q2 2018$53,000
-78.2%
1,700
-85.5%
0.00%
-66.7%
Q1 2018$243,000
+3.0%
11,7000.0%0.00%
+50.0%
Q4 2017$236,000
-0.8%
11,700
-2.5%
0.00%
-33.3%
Q3 2017$238,000
+88.9%
12,000
+20.0%
0.00%
+200.0%
Q2 2017$126,00010,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q4 2021
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$29,071,00012.94%
HARTLINE INVESTMENT CORP/ 302,194$67,033,0008.47%
Deep Track Capital, LP 1,000,000$82,850,0005.31%
MORGAN JESS S & CO INC 48,860$4,048,0002.94%
Taylor Frigon Capital Management LLC 73,014$6,049,0002.24%
Private Harbour Investment Management & Counsel, LLC 13,263$1,099,0000.92%
HighVista Strategies LLC 17,448$1,446,0000.92%
COURAGE CAPITAL MANAGEMENT LLC 10,000$829,0000.79%
Lloyd Park, LLC 6,700$555,0000.61%
Rhenman & Partners Asset Management AB 69,700$5,775,0000.57%
View complete list of NOVOCURE LTD shareholders